Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Ultraviolet blood irradiation therapy: Further studies in acute infections *


1. The study of the clinical effects of ultraviolet blood irradiation in 445 consecutive and unselected cases of acute pyogenic infections has been made. Confirmation of our original preliminary findings was observed. These findings showed that ultraviolet blood irradiation therapy was a rapid, efficient and non-specific control of all types of acute pyogenic infections (except bacterial endocarditis), the use of which was characterized by a quick subsidence of toxic symptoms, a disappearance of bacterial proliferation and invasion and an uneventful convalescence.


2. In seventy-four consecutive and unselected cases of virus or virus-like infections we have observed results comparable to the favorable effects observed in its use in acute pyogenic infections.


3. It was found that sulfa sensitive infections are easily and favorably influenced by ultraviolet blood irradiation therapy and that a large variety of infections not controlled by sulfa drugs can be rapidly and efficiently controlled by ultraviolet blood irradiation therapy.


4. Many penicillin-resistant infections respond favorably to ultraviolet blood irradiation therapy, both the acute pyogenic types and the virus or virus-like infections.


5. We were able to confirm the preoperative protective effect of ultraviolet blood irradiation therapy described by Rebbeck and fittingly called the Rebbeck Effect.


6. There is no contraindication to the joint use of penicillin and ultraviolet blood irradiation therapy, but sulfa drugs cannot be safely used in the first four or five days following ultraviolet blood irradiation therapy.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 05-24-2013